Navios Maritime Holdings Inc. Extends Exchange Offer & Waives Condition
Nov 01, 2016 12:56 pm UTC| Business
MONACO, Nov. 01, 2016 -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) today announced that, in connection with its previously launched exchange offer and consent solicitation (the “Exchange Offer”)...
Chembio’s DPP® Zika Test Approved by Brazil’s Health Regulatory Agency
Nov 01, 2016 12:50 pm UTC| Business
MEDFORD, N.Y., Nov. 01, 2016 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received approval for commercial use of its...
KnowBe4 Introduces Partner Program for North America
Nov 01, 2016 12:35 pm UTC| Business
TAMPA BAY, Fla., Nov. 01, 2016 -- Knowing partners are the cornerstone to success, KnowBe4, provider of the world’s most popular platform for security awareness training and simulated phishing attacks, today announced...
Nov 01, 2016 12:30 pm UTC| Business
VANCOUVER, British Columbia, Nov. 01, 2016 -- Cuba Ventures Corp. (TSX-V:CUV) (OTCBB:MPSFF) (Frankfurt:IJA2) (the “Company”) is pleased to provide a corporate update now that its first full Quarterly Financial...
Nov 01, 2016 12:30 pm UTC| Business
MINNEAPOLIS, Nov. 01, 2016 -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing...
McDermott Opens New 300-Person Office in Kingdom of Saudi Arabia
Nov 01, 2016 12:30 pm UTC| Business
New office adds space for up to 300 staff and expands McDermott’s engineering capacity and Saudi operationsMcDermott to significantly increase in-Kingdom contribution in support of Saudi Arabia’s Vision 2030 HOUSTON, Nov....
Corvus Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference
Nov 01, 2016 12:30 pm UTC| Business
BURLINGAME, Calif., Nov. 01, 2016 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today...